KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Invested Capital (2016 - 2025)

Fulgent Genetics' Return on Invested Capital history spans 10 years, with the latest figure at 0.08% for Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 25.0% year-over-year to 0.08%; the TTM value through Sep 2025 reached 0.08%, up 25.0%, while the annual FY2024 figure was 0.04%, 20.0% up from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.08% at Fulgent Genetics, up from 0.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 1.22% in Q4 2022 and bottomed at 0.17% in Q2 2024.
  • The 5-year median for Return on Invested Capital is 0.08% (2025), against an average of 0.17%.
  • The largest annual shift saw Return on Invested Capital tumbled -101191bps in 2021 before it soared 77bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.45% in 2021, then soared by 172bps to 1.22% in 2022, then tumbled by -113bps to 0.16% in 2023, then soared by 123bps to 0.04% in 2024, then soared by 122bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Return on Invested Capital are 0.08% (Q3 2025), 0.03% (Q2 2025), and 0.11% (Q1 2025).